Search Results for: MBIO
Adaptive Biotechnologies intends to price 15 million shares to reslut in an initial public offering valued up to more than $327 million.
Published:
Catalyst Biosciences saw its shares practically triple in Tuesday’s session after the company announced a critical regulatory approval.
Published:
Last Updated:
Viela Bio filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its IPO. The company intends to price 7.5 million shares in the range of $19 to $21, with an...
Published:
Clinical-stage biotechnology company Stealth Biotherapeutics has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Unity Biotechnology stock was absolutely crushed on Monday after the company announced results from its midstage study in patients with moderate-to-severe painful osteoarthritis of the knee.
Published:
According to The Guardian "The US is flooding Europe with subsidised biofuels that threaten to destroy Europe’s domestic refining market, the head of the biofuel company D1 Oils warned...
Published:
Caladrius Biosciences watched its shares soar on Thursday after the company announced a private placement offering.
Published:
Last Updated:
Source: ThinkstockMonday’s stock market sell-off may have looked harsh as the Greece exit of the Euro looks closer and closer. Municipal bond investors now have a much larger risk in the United...
Published:
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger...
Published:
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Published:
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
Published:
Last Updated:
Bio Blast Pharma was blowing away all the other bulls in Wednesday’s session, with its stock up over 150% on positive clinical results.
Published:
Last Updated:
vTv Therapeutics watched its shares make a massive gain early on Thursday after the firm announced an exclusive licensing agreement with Newsoara Biopharma.
Published:
Last Updated:
Adverum Biotechnologies shares made a handy gain on Thursday after the company announced a key update from the FDA.
Published:
Last Updated: